This story was originally published Oct. 14.
Helicos BioSciences said last week that it has appointed Ivan Trifunovich as its new president and CEO, replacing Ron Lowy, who will remain on the company's board of directors. The firm also launched a licensing program for its single-molecule sequencing technology.
Trifunovich has served as a consultant for Helicos since August. Most recently, he was a strategic consultant to global life sciences companies, and before that, senior vice president of Third Wave Technologies.